SUVEN LIFE SCIENCES LTD. - Outcome of QIP Committee Meeting

Suven Life Sciences Ltd has informed BSE that the QIP Committee (the "Committee") of the Board of Directors of the Company at its meeting held on December 03, 2014, has approved the allotment of 1,04,53,690 Equity shares of face value of Re. 1/- each at a premium of Rs. 190.32 per equity share aggregating to Rs. 20,000 lakhs.